Please rate this video

IMW 2019 | Using immunopaths to image residual disease

Please rate this video

Ola Landgren

Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses his research into immunopaths and describes the method by which he was successful in imaging potential residual disease that would not otherwise have been visible using blood tests or biopsies. This interview was recorded at the international myeloma workshop (IMW) 2019, in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter